in

The Future of Biotechnology: A Conversation with Fabian Hansen, Co-Founder & General Partner of Presight Capital #TFIN

# Fabian Hansen on the Future of Biotechnology

If you’re interested in the latest trends in the biotechnology sector, then this interview with Fabian Hansen, co-founder and general partner of Presight Capital, is for you! As an investor on the Forbes 30Under30 list, Hansen has built an $80 million dollar fund for hard-tech in the USA and has invested in over 30 startups in the biotechnology field.

In this interview, he discusses the huge market opportunity in biotechnology, the rapid changes in the industry over the last few years, and how the next decade will revolutionize the pharma industry. Hansen also shares insights on the recent IPO of the first Magic Mushroom company, the potential of alternative medicine to solve mental health problems, and the positive impact of COVID-19 on the biotech industry.

Learn more about Hansen and Presight Capital on Forbes DACH’s YouTube channel and check out their website for more information.

## About Forbes DACH
Forbes DACH is a leading source of news, analysis, and insights for entrepreneurs and investors in the German-speaking region. Stay up-to-date on the latest business and technology trends by subscribing to their newsletter and following them on social media:

– Website: https://www.forbes.at/f15.html
– Newsletter: https://www.forbes.at/newsletter.html
– Facebook: https://www.facebook.com/ForbesDACH/
– LinkedIn: https://www.linkedin.com/company/forbesdach/
– Twitter: https://twitter.com/Forbes_DACH
– Instagram: https://www.instagram.com/forbesdach/?hl=de

Jetzt unseren Channel abonnieren: https://www.youtube.com/channel/UCBup1JzXecZwTx0eAu4jZvw/featured

Fabian Hansen ist Gründer, Investor und auf der Forbes 30Under30 Liste. Mit Presight Capital hat er einen 80 Millionen Dollar Fund für Hard-Tech in den USA aufgebaut und bisher in über 30 Startups investiert, vor allem im Biotechnologie-Bereich. Der Generalist spricht über die große Marktopportunität im Biotechnologiesektor, wie sich dieser rasant verändert hat in den letzten Jahren und wie die nächste Dekade den Pharma-Bereich auf den Kopf stellen wird. Wir sprechen über den Börsengang der ersten Magic Mushroom Firma, welche Chance „Alternativmedizin“ bietet um geistige Gesundheitsprobleme zu lösen, ob wir der Unsterblichkeit näher kommen werden und welchen positiven Impact Covid-19 auf die Branche hat.

Visit our website: https://www.forbes.at/f15.html
Subscribe to our Newsletter: https://www.forbes.at/newsletter.html
Forbes DACH on Facebook: https://www.facebook.com/ForbesDACH/
Forbes DACH on Linkedin: https://www.linkedin.com/company/forbesdach/
Forbes DACH on Twitter: https://twitter.com/Forbes_DACH
Forbes DACH on Instagram: https://www.instagram.com/forbesdach/?hl=de

#FabianHansen #PresightCaptial #Entrepreneur #Startup #Covid19 #digital #f15 #ForbesTV #TheFutureIsNow #TFIN #CamillaSievers #ForbesDACH

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

One Comment

Venture Capital Investor Positioning (with Point Nine Investor Christoph Janz)

“JPMorgan Settles Lawsuit with Jeffrey Epstein’s Victims – Restitution Acknowledged”